Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples